Benoist H - Search Results

1

Knowledge and practices about safe handling regarding the risk of exposure to antineoplastic drugs for caregivers in compounding units and in operating rooms performing HIPEC/PIPAC.

Delafoy C, Benoist H, Patin A, Vasseur M, Guillouet S, Eveno C, Guilloit JM, Odou P, Simon N, Saint-Lorant G. Delafoy C, et al. Among authors: benoist h. J Oncol Pharm Pract. 2023 Oct;29(7):1628-1636. doi: 10.1177/10781552221144303. Epub 2022 Dec 13. J Oncol Pharm Pract. 2023. PMID: 36514878

2

Appropriate use of antifungals: impact of an antifungal stewardship program on the clinical outcome of candidaemia in a French University Hospital.

Benoist H, Rodier S, de La Blanchardière A, Bonhomme J, Cormier H, Thibon P, Saint-Lorant G. Benoist H, et al. Infection. 2019 Jun;47(3):435-440. doi: 10.1007/s15010-018-01264-4. Epub 2019 Feb 26. Infection. 2019. PMID: 30806974

3

La Commission du médicament et des dispositifs médicaux stériles.

Benoist H, Augry-Guy F, Saint-Lorant G. Benoist H, et al. Rev Infirm. 2019 Apr;68(250):53-54. doi: 10.1016/j.revinf.2019.03.020. Rev Infirm. 2019. PMID: 31147082 French. No abstract available.

4

[A multidisciplinary collaboration for the benefit of patients].

Benoist H, Dinahet A, Clément C, Saint-Lorant G. Benoist H, et al. Rev Infirm. 2019 Nov;68(255):42-44. doi: 10.1016/j.revinf.2019.09.012. Rev Infirm. 2019. PMID: 31757331 Review. French.

5

Does equipment change impact blood contamination with irinotecan and its two major metabolites in a centralized cytotoxic pharmacy unit?

Benoist H, Breuil C, Le Neindre B, Delépée R, Saint-Lorant G. Benoist H, et al. J Oncol Pharm Pract. 2020 Dec;26(8):1823-1828. doi: 10.1177/1078155220905013. Epub 2020 Feb 19. J Oncol Pharm Pract. 2020. PMID: 32075506

6

Effect of a prospective audit with intervention and feedback on Clostridioides difficile infection management.

Benoist H, de La Blanchardière A, Flatres A, Isnard C, Thibon P, Saint-Lorant G. Benoist H, et al. Int J Clin Pharm. 2020 Jun;42(3):923-930. doi: 10.1007/s11096-020-01050-z. Epub 2020 May 15. Int J Clin Pharm. 2020. PMID: 32410207

7

Blood contamination of the pharmaceutical staff by irinotecan and its two major metabolites inside and outside a compounding unit.

Béchet V, Benoist H, Beau F, Divanon F, Lagadu S, Sichel F, Delépée R, Saint-Lorant G. Béchet V, et al. Among authors: benoist h. J Oncol Pharm Pract. 2022 Jun;28(4):777-784. doi: 10.1177/10781552211012059. Epub 2021 Apr 20. J Oncol Pharm Pract. 2022. PMID: 33878975

8

Impact of low- and high-risk operators handling irinotecan on the blood contamination of health care workers in oncology day care units.

Pirot C, Benoist H, Lagadu S, Delépée R, Saint-Lorant G. Pirot C, et al. Among authors: benoist h. J Oncol Pharm Pract. 2023 Jun;29(4):905-911. doi: 10.1177/10781552221090965. Epub 2022 Apr 5. J Oncol Pharm Pract. 2023. PMID: 35382645

9

Perception, knowledge, and handling practice regarding the risk of exposure to antineoplastic drugs in oncology day hospitalization units and compounding unit staff.

Benoist H, Busson A, Faveyrial A, Bouhier-Leporrier K, Divanon F, Breuil C, Roger-Leenaert S, Palix A, Odou P, Simon N, Saint-Lorant G. Benoist H, et al. J Oncol Pharm Pract. 2022 May 29:10781552221103803. doi: 10.1177/10781552221103803. Online ahead of print. J Oncol Pharm Pract. 2022. PMID: 35635230

10

Perception, knowledge and protective practices for surgical staff handling antineoplastic drugs during HIPEC and PIPAC.

Benoist H, Eveno C, Wilson S, Vigneron N, Guilloit JM, Morello R, Simon N, Odou P, Saint-Lorant G. Benoist H, et al. Pleura Peritoneum. 2022 Apr 13;7(2):77-86. doi: 10.1515/pp-2021-0151. eCollection 2022 Jun 1. Pleura Peritoneum. 2022. PMID: 35812009 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

118 results

Search Page